RecruitingNot ApplicableNCT03667599
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
Sponsor
Duke University
Enrollment
150 participants
Start Date
Sep 28, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria8
- Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
- Age 18-80 years
- Karnofsky Performance Scale KPS> 80
- Able to read/write English
- A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
- Identified by patient as their primary caregiver
- Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
- Age 18-80 years
Exclusion Criteria5
- Lack of a caregiver
- Pregnant women
- Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
- Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERhome care
This is the interventional arm where patients receive the transplant care in their homes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03667599